{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:40:30Z","timestamp":1694065230187},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.2515\/therapie:2007066","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T14:51:45Z","timestamp":1200667905000},"page":"449-453","source":"Crossref","is-referenced-by-count":4,"title":["Traitement neuroleptique et signes neurologiques mineurs chez les patients schizophr\u00e8nes"],"prefix":"10.1016","volume":"62","author":[{"given":"Anwar","family":"Mechri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9la","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabeur","family":"Chebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfa","family":"Mandhouj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotfi","family":"Gaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2007066_bb0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1192\/bjp.158.6.770","article-title":"The clinical correlates of neurological soft signs in chronic schizophrenia","volume":"158","author":"King","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/ajp.152.2.191","article-title":"Neurological soft signs in neurolepticnaive and neuroleptic-treated schizophrenic patients and in normal comparison subjects","volume":"152","author":"Gupta","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0920-9964(97)00150-3","article-title":"Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates","volume":"30","author":"Ismail","year":"1998","journal-title":"Schizophr Res"},{"key":"10.2515\/therapie:2007066_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(99)00206-6","article-title":"Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia","volume":"45","author":"Krebs","year":"2000","journal-title":"Schizophr Res"},{"key":"10.2515\/therapie:2007066_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(01)00338-3","article-title":"Neurological soft signs in schizophrenic patients and their non psychotic siblings","volume":"58","author":"Yazisi","year":"2002","journal-title":"Schizophr Res"},{"key":"10.2515\/therapie:2007066_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-1781(03)00126-4","article-title":"Influence of antipsychotic agents on neurological soft signs and dyskinesia in first episode psychosis","volume":"119","author":"Boks","year":"2003","journal-title":"Psychiatr Res"},{"key":"10.2515\/therapie:2007066_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.jcp.0000169268.44421.cf","article-title":"Neurological soft signs in schizophrenic patients treated with conventional and atypical antipsychotics","volume":"25","author":"Bersani","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.2515\/therapie:2007066_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.schbul.a033421","article-title":"Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests","volume":"25","author":"Smith","year":"1999","journal-title":"Schizophrenia Bull"},{"key":"10.2515\/therapie:2007066_bb0045","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0006-3223(96)00251-X","article-title":"Neurological soft signs and response to risperidone in chronic schizophrenia","volume":"40","author":"Smith","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0447.1990.tb03070.x","article-title":"Predicting neuroleptic response from a combination of multilevel variables in acute schizophrenic patients","volume":"82","author":"Bartko","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.2515\/therapie:2007066_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.146.3.229","article-title":"Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction","volume":"146","author":"Kolakowska","year":"1985","journal-title":"Br J Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0060","first-page":"13","article-title":"Treatment refractory schizophrenia","volume":"21","author":"Vanelle","year":"1995","journal-title":"L\u2019Encephale"},{"key":"10.2515\/therapie:2007066_bb0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbi028","article-title":"Significance and meaning of neurological signs in schizophrenia: two decades later","volume":"31","author":"Bombin","year":"2005","journal-title":"Schizophrenia Bull"},{"key":"10.2515\/therapie:2007066_bb0070","series-title":"Diagnostic and Statistical Manuel of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.2515\/therapie:2007066_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bull"},{"key":"10.2515\/therapie:2007066_bb0080","series-title":"National Institute of Mental Health","article-title":"Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.2515\/therapie:2007066_bb0085","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"10.2515\/therapie:2007066_bb0095","series-title":"10.0. Statistical Package for the Social Sciences (SPSS) for windows, version 10.0","author":"SPSS","year":"1994"},{"key":"10.2515\/therapie:2007066_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0920-9964(91)90017-L","article-title":"Neurological soft signs in schizophrenia","volume":"6","author":"Schroder","year":"1992","journal-title":"Schizophr Res"},{"key":"10.2515\/therapie:2007066_bb0105","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1017\/S003329179900286X","article-title":"Determinants of neurological dysfunction in first episode schizophrenia","volume":"30","author":"Browne","year":"2000","journal-title":"Psychol Med"},{"key":"10.2515\/therapie:2007066_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0447.2003.00113.x","article-title":"Neurological Soft signs in never-treated schizophrenia","volume":"108","author":"Venkatasubramanian","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.2515\/therapie:2007066_bb0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-1781(00)00176-1","article-title":"Factor structure of neurologic examination abnormalities in unmedicated schizophrenia","volume":"95","author":"Sanders","year":"2000","journal-title":"Psychiatr Res"},{"key":"10.2515\/therapie:2007066_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0447.1999.tb10832.x","article-title":"Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5years after first admission","volume":"100","author":"Madsen","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.2515\/therapie:2007066_bb0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1192\/bjp.178.6.524","article-title":"Neurodeveloppemental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia","volume":"178","author":"Lawrie","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1176\/jnp.11.1.91","article-title":"Stability of Neurological Soft Signs in Chronically Hospitalized Schizophrenic patients","volume":"11","author":"Smith","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.2515\/therapie:2007066_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0920-9964(89)90008-X","article-title":"Neurological features, cognitive impairment and neuroleptic response in schizophrenic patients","volume":"2","author":"Bartko","year":"1989","journal-title":"Schizophr Res"},{"key":"10.2515\/therapie:2007066_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1176\/ajp.151.1.49","article-title":"Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia","volume":"151","author":"Convit","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0145","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-3223(97)00442-3","article-title":"D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography","volume":"43","author":"Schroder","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2005.06.012","article-title":"Neurological soft signs and positive treatment response to olanzapine in chronic schizophrenia","volume":"30","author":"Sevincok","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0155","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0278-5846(01)00318-9","article-title":"Biological markers and possibilities for predicting therapeutic results in schizophrenia","volume":"26","author":"Ceskova","year":"2002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.2515\/therapie:2007066_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/oxfordjournals.schbul.a007075","article-title":"Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia","volume":"30","author":"Das","year":"2004","journal-title":"Schizophrenia Bull"},{"key":"10.2515\/therapie:2007066_bb0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpsychires.2005.03.008","article-title":"Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia","volume":"40","author":"Prikry","year":"2006","journal-title":"J Psychiatr Res"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716305042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716305042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:07:51Z","timestamp":1554275271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716305042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0040595716305042"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2007066","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}